Stay updated on MEDI8897 for RSV Prevention in High-risk Kids Clinical Trial
Sign up to get notified when there's something new on the MEDI8897 for RSV Prevention in High-risk Kids Clinical Trial page.

Latest updates to the MEDI8897 for RSV Prevention in High-risk Kids Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedCore page content updated to include a funding-status notice and operating-status guidance, plus a version upgrade from v3.1.0 to v3.2.0.SummaryDifference3%

- Check27 days agoChange DetectedReleased a new version: v3.1.0, replacing the previous v3.0.2. This is primarily a version update to the core content.SummaryDifference0.1%

- Check41 days agoChange DetectedThe location string is updated to México with the same 06720 code, and the revision is bumped to v3.0.2. The Back to Top link was removed.SummaryDifference0.2%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check56 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as updated drug information for Nirsevimab. The previous drug information for Palivizumab has been removed.SummaryDifference10%

- Check70 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to MEDI8897 for RSV Prevention in High-risk Kids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI8897 for RSV Prevention in High-risk Kids Clinical Trial page.